GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order:
GlaxoSmithKline Pharmaceuticals made a disclosure in front of NSE and BSE that it has received an order from the West Bengal GST authorities demanding a penalty from the company.
GlaxoSmithKline Pharmaceuticals Receive GST Order
Shriya Mishra
Jun 27, 2025GlaxoSmithKline Receives Rs. 3.36 Cr GST Demand Order
Mumbai-based pharmaceutical company GlaxoSmithKline received an order on 24th June 2025, from the Commissioner, CGST & CX, Appeals-II, Kolkata, regarding Disallowance of transitional credit (TRAN 1 & TRAN 2 credit) for FY 2017–18.
The said authority has raised a total demand of Rs. 3,39,09,520 from the company.
The company made disclosure of the matter to the National Stock Exchange of India and BSE in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also stated that there is no impact on the financial operations of the organization, and it is evaluating the order and will take necessary steps regarding the same.
About Author
Shriya Mishra
Content Writer
Shriya writes engaging and easy-to-understand content on budgeting, mutual funds, insurance, income tax, GST, company law and financial planning. Her mission is to guide readers toward smarter money habits and long-term wealth creation. She can be reached at [email protected]
Studycafe
Delhi, Delhi, India
56My Recent Articles
- Income Tax Dept Breaks Silence: No Mass Scrutiny for Small Taxpayers
- GST Return Filing to Get Tougher from July 1: Major Changes You Must Know
- Tax Trouble for Delhivery: Rs. 1.36 Cr Penalty Order from Income Tax
- Canada to remove Digital Services Tax to Restart Trade Talks with US
- IEC Update Deadline Ends Today: Don't Miss Final Date to Avoid Penalties
Up Next
Loading suggestions…
Recent Posts
All Posts
Recent Posts
All Posts